XTNT - Xtant Medical Holdings, Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD
6.14
+0.24 (+4.07%)
At close: 3:54PM EDT
Stock chart is not supported by your current browser
Previous Close5.90
Open5.96
Bid5.51 x 800
Ask0.00 x 800
Day's Range5.97 - 6.09
52 Week Range3.96 - 14.52
Volume4,724
Avg. Volume29,957
Market Cap80.712M
Beta-0.59
PE Ratio (TTM)N/A
EPS (TTM)-17.27
Earnings DateJul 31, 2017 - Aug 4, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.00
Trade prices are not sourced from all markets
  • GlobeNewswire7 days ago

    Xtant Medical Appoints Kevin Brandt as Chief Commercial Officer

    Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced the appointment of Kevin Brandt to the new executive position of Chief Commercial Officer effective July 9, 2018. “We are excited to have such a talented and experienced executive officer join our team,” said Carl O’Connell, chief executive officer of Xtant. “Kevin’s past accomplishments in the medical device industry show that he is an accomplished business strategist with a unique ability to provide the leadership in sales and marketing to build our Company’s revenues and profitability.

  • GlobeNewswire28 days ago

    Xtant Medical Holdings, Inc. Announces Expiration of Rights Offering

    XtantTM Medical Holdings, Inc. (NYSE American: XTNT) announces that the subscription period for its previously announced rights offering (the “Offering”) of shares of the Company’s common stock at a subscription price of $7.20 per share expired on June 18, 2018, and these rights are no longer exercisable. Based on the review of preliminary results provided by the Company’s subscription agent, Corporate Stock Transfer, Inc., Xtant Medical expects to issue 129 shares of common stock in the Offering.

  • What Investors Should Know About Xtant Medical Holdings Inc’s (NYSEMKT:XTNT) Financial Strength
    Simply Wall St.last month

    What Investors Should Know About Xtant Medical Holdings Inc’s (NYSEMKT:XTNT) Financial Strength

    Investors are always looking for growth in small-cap stocks like Xtant Medical Holdings Inc (AMEX:XTNT), with a market cap of US$75.06M. However, an important fact which most ignore is: howRead More...

  • ACCESSWIRE2 months ago

    Xtant Medical Receives FDA 510(K) Clearance for InTice(TM)-C Porous Titanium Cervical Interbody System

    BELGRADE, MT / ACCESSWIRE / May 21, 2018 / Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development of regenerative medicine products and medical devices, announces U.S. Food and Drug Administration (FDA) 510(k) clearance for InTice™-C Porous Titanium Cervical Interbody System. InTice-C is designed using OsteoSync Ti, a best-in-class, cost-effective, highly porous titanium scaffold material for improved implant fixation. The material more closely resembles the bioscaffold of cancellous bone, and further combines Xtant Medical's hardware and biologic portfolios.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of XTNT earnings conference call or presentation 9-May-18 1:00pm GMT

    Q1 2018 Xtant Medical Holdings Inc Earnings Call

  • ACCESSWIRE2 months ago

    Xtant Medical Announces First Quarter 2018 Financial Results

    BELGRADE, MT / ACCESSWIRE / May 8, 2018 / Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development of regenerative medicine products and medical devices, today reported financial ...

  • ACCESSWIRE2 months ago

    Xtant Medical to Issue First Quarter 2018 Results on May 8th, 2018

    BELGRADE, MT / ACCESSWIRE / May 2, 2018 / Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that it will release its financial results for the quarter ended March 31, 2018, after the close of the financial markets on Tuesday, May 8, 2018. An accompanying conference call will be conducted by Carl O'Connell, Chief Executive Officer and President, and Laura Kendall, Interim Chief Financial Officer, to review the results. Please refer to the information below for conference call dial-in information and webcast registration.

  • ACCESSWIRE3 months ago

    Xtant Medical Holdings, Inc. Announces Record Date for Proposed Rights Offering

    BELGRADE, MT / ACCESSWIRE / April 17, 2018 / Xtant™ Medical Holdings, Inc. (NYSE American: XTNT) announced today that it has set April 27, 2018 as the record date for a proposed rights offering of its ...

  • What Is Xtant Medical Holdings Inc’s (NYSEMKT:XTNT) Share Price Doing?
    Simply Wall St.3 months ago

    What Is Xtant Medical Holdings Inc’s (NYSEMKT:XTNT) Share Price Doing?

    Xtant Medical Holdings Inc (AMEX:XTNT), a medical equipment company based in United States, led the AMEX gainers with a relatively large price hike in the past couple of weeks. Less-covered,Read More...

  • ACCESSWIRE3 months ago

    Xtant Medical Holdings, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / April 3, 2018 / Xtant Medical Holdings, Inc. (NYSE American: XTNT ) will be discussing their earnings results in their Q4 Earnings Call to be held on April 3, 2018, at 9:00 ...

  • ACCESSWIRE3 months ago

    Xtant Announces Fourth Quarter and Year End 2017 Financial Results

    BELGRADE, MT / ACCESSWIRE / April 2, 2018 / Xtant™ Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development of regenerative medicine products and medical devices, today reported its financial ...

  • ACCESSWIRE4 months ago

    Xtant Medical to Issue Fourth Quarter and Full Year 2017 Financial Results Monday, April 2

    BELGRADE, MT / ACCESSWIRE / March 27, 2018 / Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that ...

  • Why Did Xtant Medical Holdings Inc (XTNT) Shares Shoot the Lights Out Today?
    SmarterAnalyst5 months ago

    Why Did Xtant Medical Holdings Inc (XTNT) Shares Shoot the Lights Out Today?

    Xtant Medical Holdings Inc (NYSEAMERICAN:XTNT) announced today that it received notice from the New York Stock Exchange (NYSE) on February 15, 2018 that the Company has regained compliance with the NYSE’s continued listing standards. The Company will continue to trade on the NYSE American exchange under the symbol “XTNT”. As previously announced, on January 7, 2018, the Company entered into a Restructuring and Exchange Agreement with ROS Acquisition Offshore LP, OrbiMed Royalty Opportunities II, and all of the other holders of all of Xtant's outstanding 6.00% convertible senior unsecured notes due 2021 on January 11, 2017.

  • Who Really Owns Xtant Medical Holdings Inc (NYSEMKT:XTNT)?
    Simply Wall St.6 months ago

    Who Really Owns Xtant Medical Holdings Inc (NYSEMKT:XTNT)?

    In this analysis, my focus will be on developing a perspective on Xtant Medical Holdings Inc’s (AMEX:XTNT) latest ownership structure, a less discussed, but important factor. Ownership structure has beenRead More...

  • Before You Buy Xtant Medical Holdings Inc’s (NYSEMKT:XTNT), You Should Consider This
    Simply Wall St.6 months ago

    Before You Buy Xtant Medical Holdings Inc’s (NYSEMKT:XTNT), You Should Consider This

    If you are looking to invest in Xtant Medical Holdings Inc’s (AMEX:XTNT), or currently own the stock, then you need to understand its beta in order to understand how itRead More...

  • What’s Ahead For Xtant Medical Holdings Inc (NYSEMKT:XTNT)?
    Simply Wall St.6 months ago

    What’s Ahead For Xtant Medical Holdings Inc (NYSEMKT:XTNT)?

    Xtant Medical Holdings Inc (AMEX:XTNT), a USD$10.47M small-cap, operates in the healthcare industry, which faces more complex and interdependent challenges, requiring multi-pronged, collaborative, and technology-enabled business models. Healthcare analysts areRead More...

  • Is Xtant Medical Holdings Inc’s (NYSEMKT:XTNT) CEO Pay Fair?
    Simply Wall St.7 months ago

    Is Xtant Medical Holdings Inc’s (NYSEMKT:XTNT) CEO Pay Fair?

    Carl O’Connell has been at the helm as CEO of Xtant Medical Holdings Inc (AMEX:XTNT), which has grown to a market capitalization of $10.36M. Recognizing whether CEO incentives are alignedRead More...

  • Xtant Medical Holdings, Inc. :XTNT-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017
    Capital Cube7 months ago

    Xtant Medical Holdings, Inc. :XTNT-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017

    Categories: Yahoo FinanceGet free summary analysis Xtant Medical Holdings, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Xtant Medical Holdings, Inc. – Alphatec Holdings, Inc., Globus Medical, Inc. Class A, Exactech, Inc., RTI Surgical, Inc., CONMED Corporation and Orthofix International NV (ATEC-US, GMED-US, EXAC-US, ... Read more (Read more...)

  • At $0.5795, Is It Time To Buy Xtant Medical Holdings Inc (NYSEMKT:XTNT)?
    Simply Wall St.7 months ago

    At $0.5795, Is It Time To Buy Xtant Medical Holdings Inc (NYSEMKT:XTNT)?

    Xtant Medical Holdings Inc (AMEX:XTNT), a medical equipment company based in United States, received a lot of attention from a substantial price movement on the AMEX in the over theRead More...

  • Thomson Reuters StreetEvents8 months ago

    Edited Transcript of XTNT earnings conference call or presentation 22-Nov-17 2:00pm GMT

    Q3 2017 Xtant Medical Holdings Inc Earnings Call